COLUMBIA, Md.--(BUSINESS WIRE)--
Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today its results for the fourth quarter and year ended December 31, 2007.
